| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Lizzul Paul F. is a Chief Medical Officer at ANAPTYSBIO, INC. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 3,650 | $44.71 | $163,191.50 | -8.0% | +49.6% | - | |
| Jan 7, 2026 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 2,235 | $45.11 | $100,820.85 | -5.7% | +37.4% | - | |
| Jan 5, 2026 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 4,219 | $43.26 | $182,513.94 | -11.2% | +44.5% | - | |
| Dec 22, 2025 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 1,500 | $50.00 | $75,000.00 | -5.3% | +24.6% | - | |
| Sep 23, 2024 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 1,500 | $38.67 | $58,005.00 | -8.9% | -60.7% | -41.1% | |
| Sep 16, 2024 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 2,220 | $38.93 | $86,424.60 | -12.6% | -57.0% | -49.9% | |
| Aug 14, 2024 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 2,000 | $40.00 | $80,000.00 | -14.7% | -38.0% | -42.4% | |
| Jul 18, 2024 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 1,500 | $35.00 | $52,500.00 | -11.4% | +0.7% | -24.8% | |
| Jan 8, 2024 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 2,554 | $21.81 | $55,702.74 | -20.2% | -8.3% | -34.3% | |
| Sep 14, 2023 | ANAB Anaptysbio, Inc | Chief Medical Officer | Sale+OE | 2,105 | $19.48 | $41,005.40 | -24.4% | -7.1% | +105.0% |